Key Insights

Highlights

Treatment Research

2 treatments under study, led by Alpco Syphilisnt Clia Kits

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT07089836Recruiting

This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasma. Samples From At-risk, HIV-positive, Pregnant, and Healthy Individuals Will Assess Assay Performance Versus Established Comparator Tests.

NCT01045824Unknown

Family-based Genetic Long-term Study of Brain Function in Schizophrenia

Showing all 2 trials

Research Network

Common Treatments

  • Alpco Syphilisnt Clia Kits1
  • Alpco Syphilist1

Active Sponsors

  • Taichung Veterans General Hospital1
  • American Laboratory Products Company1

Top Investigators

Related Conditions

  • Syphilis Infection1
  • Schizophrenia1
  • Treponema Pallidum1
  • Plasma1
  • Treponema Pallidum Infection1

Activity Timeline